WHO ICTRP trial
Vonoprazan-Doxycycline Dual Therapy Versus Bismuth-Containing…
ChiCTR2500115106 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500115106 |
|---|---|
| Public title | Vonoprazan-Doxycycline Dual Therapy Versus Bismuth-Containing Doxycycline-Furazolidone Quadruple Therapy as Rescue Treatment for Helicobacter pylori: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial |
| Scientific title | Vonoprazan-Doxycycline Dual Therapy Versus Bismuth-Containing Doxycycline-Furazolidone Quadruple Therapy as Rescue Treatment for Helicobacter pylori: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial |
| Primary sponsor | NanJing First Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | helicobacter pylori infection |
| Interventions | Group B:Doxycycline dual therapy;Group A:Bismuth quadruple solution |
| Registration date | Dec 22, 2025 |
| Target size | Group B:133;Group A:133 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: